Understanding how young people with HIV in Ghana respond to a new treatment
PHARMACOKINETICS AND PHARMACOGENOMICS OF DOLUTEGRAVIR-BASED ANTIRETROVIRAL THERAPY IN YOUNG PEOPLE LIVING WITH HIV IN GHANA (PHARMA-YOUNG-HIV)
This study is looking at how well young people with HIV in Ghana respond to a newer HIV medication called dolutegravir, to see how it works for them and if there are any side effects, so we can make their treatment better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Ghana Medical Centre NIH-funded |
| Lab location | 1 site (Accra, Ghana) |
| Project ID | NIH-11007344 on NIH RePORTER |
What this research studies
This research investigates how young people living with HIV in Ghana metabolize dolutegravir-based antiretroviral therapy. It aims to understand the effectiveness and potential side effects of this treatment in a population that has recently switched from older medications. By studying drug concentrations and patient responses, the research seeks to identify any issues related to treatment adherence and adverse effects. The findings could help improve treatment strategies for young people with HIV in sub-Saharan Africa.
Who could benefit from this research
Good fit: Ideal candidates for this research are young people aged 10-24 years living with HIV in Ghana who are receiving dolutegravir-based therapy.
Not a fit: Patients outside the age range of 10-24 years or those not receiving dolutegravir-based therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment protocols for young people living with HIV, enhancing their health outcomes.
How similar studies have performed: While there have been studies on dolutegravir in adults, this specific focus on young people in Ghana is novel and has not been extensively tested.
Where this research is happening
Accra, Ghana
- University of Ghana Medical Centre — Accra, Ghana (Active)
Researchers
- Principal investigator: Thomford, Nicholas Ekow — University of Ghana Medical Centre
- Study coordinator: Thomford, Nicholas Ekow
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.